CoChat
Sign Up
Cited by 666Salmonella and Campylobacter epidemiologyAntibiotic Resistance in BacteriaAntibiotic Use and Resistance

Quinolone-Resistant Campylobacter jejuni Infections in Minnesota, 1992–1998

Open access
Smith, Kirk E., Besser, John M., Hedberg, Craig W., Leano, Fe T., Bender, Jeffrey B., Wicklund, Julie H., Johnson, Brian P., Moore, Kristine A. +1 more·1999·New England Journal of Medicine
DOI 10.1056/nejm199905203402001
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: Increasing resistance to quinolones among campylobacter isolates from humans has been reported in Europe and Asia, but not in the United States. We evaluated resistance to quinolones among campylobacter isolates from Minnesota residents during the period from 1992 through 1998. METHODS: All 4953 campylobacter isolates from humans received by the Minnesota Department of Health were tested for resistance to nalidixic acid. Resistant isolates and selected sensitive isolates were tested for resistance to ciprofloxacin. We conducted a case-comparison study of patients with ciprofloxacin-resistant Campylobacter jejuni isolated during 1996 and 1997. Domestic chicken was evaluated as a potential source of quinolone-resistant campylobacter. RESULTS: The proportion of quinolone-resistant C. jejuni isolates from humans increased from 1.3 percent in 1992 to 10.2 percent in 1998 (P<0.001). During 1996 and 1997, infection with quinolone-resistant C. jejuni was associated with foreign travel and with the use of a quinolone before the collection of stool specimens. However, quinolone use could account for no more than 15 percent of the cases from 1996 through 1998. The number of quinolone-resistant infections that were acquired domestically also increased during the period from 1996 through 1998. Ciprofloxacin-resistant C. jejuni was isolated from 14 percent of 91 domestic chicken products obtained from retail markets in 1997. Molecular subtyping showed an association between resistant C. jejuni strains from chicken products and domestically acquired infections in Minnesota residents. CONCLUSIONS: The increase in quinolone-resistant C. jejuni infections in Minnesota is largely due to infections acquired during foreign travel. However, the number of quinolone-resistant infections acquired domestically has also increased, largely because of the acquisition of resistant strains from poultry. The use of fluoroquinolones in poultry, which began in the United States in 1995, has created a reservoir of resistant C. jejuni.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199905203402001

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Foodborne Diseases Active Surveillance Network, 1996. MMWR Morb Mortal Wkly Rep 1997;46:258-61.
  2. The choice of antibacterial drugs. Med Lett Drugs Ther 1998;40:33- 42.

Cited by

Sorted by citations

Related

Authors
Smith, K. E., Besser, J. M., Hedberg, C. W., Leano, F. T., Bender, J. B., Wicklund, J. H., Johnson, B. P., Moore, K. A., & Osterholm, M. T.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Minnesota Department of Health (US)
ORCID
Venue
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Published
1999-05-20
Volume
340
Issue
20
Pages
1525-1532
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
DOI
10.1056/nejm199905203402001
OpenAlex
W2342082395
Cited by
666
References
26
Citations by year
2026: 2 · 2025: 2 · 2024: 2 · 2023: 8 · 2022: 8 · 2021: 9 · 2020: 7 · 2019: 15 · 2018: 9 · 2017: 11 · 2016: 19 · 2015: 24 · 2014: 27 · 2013: 19 · 2012: 23
FWCI
118.81
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Minnesota Department of Agriculture
  • Minnesota Department of Health
  • U.S. Public Health Service (U50/CCU511190)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
Keywords
Campylobacter jejuni, quinolone resistance, ciprofloxacin resistance, nalidixic acid resistance, travel-associated infection, molecular subtyping, Minnesota
MeSH terms
Analysis of Variance, Animals, Anti-Infective Agents, Campylobacter Infections, Chickens, Ciprofloxacin, Drug Resistance, Microbial, Humans, Meat, Minnesota, Nalidixic Acid, Population Surveillance, Risk Factors, Travel, Bacterial Typing Techniques, Case-Control Studies, Campylobacter jejuni

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review